Shiseido, which has built a cell processing center in Kobe in May 2014, has obtained permission to initiate own and clinical studies based on Canada’s RepliCel hair regrowth technology (RCH-01). Using this technology, cells are collected from the back of the head, reprogrammed and transplanted.
Nikkei Biotech news release, Sept. 30, 2015
Shiseido obtains MHLW permit to implement clinical research on hair regrowth technology